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                                          INTRODUCTION 
Glaucoma is a multifactorial chronic progressive optic neuropathy which damages the optic 
nerve fibres and leads to loss of visual function. Glaucoma is found to be one of the 
irreversible causes of adult blindness all over the world1. Nearly 1 to 2 % of the population 
over 40 years old and 10 % of age more than 70 years are affected 2,3. Also these patients are 
not aware of their disease progression. So it is often referred to as the “sneak thief of sight”4. 
The main reason for underdiagnosis is lack of regular followup as quoted by Thessaloniki eye 
study as 57% 5.  
        Multiple factors such as blood pressure, intraocular pressure, auto regulatory 
mechanisms and vascular resistance are identified to be associated with pathophysiology of 
glaucoma. But IOP is the major risk factor for the development of glaucoma. So accurate 
measurement of IOP is mandatory for management and to prevent progression of glaucoma. 
At present Goldmann applanation tonometry is considered as gold standard for measuring 
IOP 6. Systemic hemodynamic factors are next most important factor contributing to the 
development of glaucoma. 
                 Sleep apnoea is specified by short interruptions of breathing pattern during sleep. 
Whereas sleep apnoea syndrome characterised by episodes of apnoea and hypopnoea during 
sleep which is followed by symptoms of functional impairment. So obstructive sleep apnea 
syndrome (OSAS) is that apnoea which results from complete or incomplete repeated 
episodes of upper pharyngeal airway obstruction during sleep which eventually leads on to 
excessive day time sleepiness and prolonged deprivation of sleep. 
         OSAS significantly raises the risk for cerebrovascular accidents, cardiac rhythm 
abnormalities and ischemic heart disease. Therefore OSAS due to its nonspecific symptoms 
14 
 
often goes undiagnosed like glaucoma. Oxygen saturation levels in tissues are reduced 
significantly in OSAS patients, which leads on to disturbances in brain metabolism and brain 
activation response. so many ocular manifestations are attributed to OSAS as a result of 
hypoperfusion of ocular tissues. 
        Recently there has been many studies trying to correlate the relationship between OSAS 
and glaucoma.This study was conducted to find the prevalence of glaucoma in OSAS 
patients. 
 
 
                                                            NEED FOR STUDY 
 
Ocular manifestations of OSAS especially glaucoma is an irreversible complication and a 
major cause of blindness next to cataract in the world, which can be prevented  if it is 
diagnosed earlier and treated effectively with current guidelines. OSAS can also be prevented 
by lifestyle modification, therefore it is necessary to find the actual association between 
glaucoma and OSAS. 
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                                      REVIEW OF LITERATURE 
 
 Dr. Drance (1973) provided for the first time the definition of glaucoma as a disease 
of the optic nerve (an optic neuropathy) caused by numerous factors, called risk 
factors. 
 In 1826, William Bowman was recommending digital palpation as part of the routine 
examination of the eye. 
 Von Graefe developed the first instrument for measuring intraocular pressure in 
1865. 
 The first applanation tonometer was introduced in 1867 by Adolph Weber. 
 Imbert (1885) and Fick (1888) developed the principle on which modern 
applanation tonometers are based. 
 Maklakoff applanation tonometer was the first reasonably accurate instrument for 
measuring the intraocular pressure of the late 19th century until relatively recently.. 
 Schiötz developed an indentation tonometer that was widely used throughout the 
world during the first two-thirds of the 20th century . 
 Goldmann's applanation tonometer of 1950 began the era of truly accurate 
intraocular pressure measurement. 
 Colin Sullivan discovered a special mask which helps human to breath during sleep. 
 Dr. Nathaniel Kleitman,  known as the “Father of American sleep research,” began 
work in the regulation of sleep and wakefulness and of circadian rhythms. 
 Kleitman described studies of sleep characteristics in different populations and the 
effect of sleep deprivation. In 1953 he and one of his students, Dr. Eugene Aserinsky, 
made the landmark discovery of rapid eye movement (REM) during sleep. 
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 Dement described “the  cyclical  nature of nocturnal sleep in 1955, and in 1957 and 
’58 established the relationship between REM sleep and dreaming”. 
 The term ‘pickwickian syndrome’ was adopted in the late 19th century to describe 
apneic symptoms, but research concentrated on the patients’ obesity rather than on 
disordered breathing during sleep. 
 The first polysomnography was recorded in 1965,recorded apnea during sleep. 
 In 1970 the first sleep clinic was established at stanford  University, california, Usa 
by William Dement.  
 First ever relationship between OSAS and glaucoma was plotted by Walsh and 
Montplaisir. 
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                                        GLAUCOMA 
The word glaucoma meant ‘clouded’ in Greek. Glaucoma is the second driving 
reason for visual deficiency around the world, with more than 50 million individuals 
influenced. Glaucoma is a multifactorial illness and its exact pathogenesis, in spite of 
broad research, stays obscure. 
The term does not refer to a single disease entity, but rather to a group of 
diseases share certain features. It is characterised as a multifactorial optic neuropathy 
with a characteristic acquired atrophy of the optic nerve and loss of retinal ganglion 
cells and their axons, and manifesting characteristic visual field abnormalities. 
AQUEOUS HUMOR INFLOW AND OUTFLOW –ANATOMY 
Aqueous inflow anatomy (i.e. site of aqueous formation) - Ciliary body 
Aqueous outflow pathway (i.e. drainage) anatomy located at the angle of anterior 
chamber 
AQUEOUS INFLOW ANATOMY: 
CILIARY BODY AND THE CILIARY PROCESSES 
The ciliary body is a part of the uveal tract. It is a triangular structure 
comprising of 
1. Ciliary body muscle 
2. Vessels 
3. Epithelia lining the ciliary processes 
4. Nerve terminals from the autonomic nervous system 
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1. Ciliary body muscle: It is a non-striated muscle. It consists of two main portions: 
Longitudinal fibres & Circular fibres 
Ciliary processes: The functional unit responsible for aqueous humor secretion 
is the ciliary process. It is a whitish finger-like projection from the pars plicata part of 
the ciliary body. 
AQUEOUS INFLOW ANATOMY  
 
 
 
 
 
 
 
                                
AQUEOUS OUTFLOW PATHWAY – ANATOMY 
Most of the aqueous drainage is through the anterior chamber angle. 
Anatomy: 
Aqueous outflow system includes: 
1. Trabecular meshwork 
i. Uveal meshwork 
ii. Juxtacanalicular (endothelial) meshwork 
iii. Corneoscleral meshwork 
19 
 
2. Schlemm’s canal 
3. Collector channel 
4. Episcleral veins 
Trabecular meshwork: 
The trabecular meshwork is a sieve-like structure bridging scleral sulcus and 
converts it into a tube - Schlemm’s canal. It consists of endogenous glycosaminoglycan 
– hyaluronic acid, chondroitin, heparin, and dermatan and keratin sulphates. The 
glycoproteins and GAG composition of the trabecular meshwork are not constant 
throughout life. Changes happen in composition as age advances, which have been 
implicated in the pathogenesis of primary open angle glaucoma. It consists of 3 
portions. 
a) Uveal meshwork 
b) Corneoscleral meshwork 
c) Juxtacanalicular meshwork 
 
  Schlemm’s canal: 
It is an oval channel embedded in the scleral sulcus. Its outer wall is lined by 
endothelial cells, which contains numerous openings of the collector channels. Torus or 
lip like thickening and septa are present to keep the canal open. 
 Collector channels: 
The outer wall of schlemm’s canal has 25 to 35 opening for the collector 
channels. They connect the schlemm’s canal to the episcleral and conjunctival veins of 
the limbal region. 
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 Episcleral veins: 
Most of the aqueous vessels drain into the episcleral veins, which ultimately 
drain into cavernous sinus via the anterior ciliary and superior ophthalmic veins. 
 
AQUEOUS OUTFLOW ANATOMY  
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AQUEOUS HUMOR 
Aqueous humor is an intraocular fluid derived from the plasma within the 
capillary network of ciliary processes. The aqueous humor circulates and enters the 
posterior chamber and takes a flows around the lens, through the pupil into the anterior 
chamber. A convection flow pattern is being created inside the anterior chamber by a 
temperature gradient (cooler toward the cornea). 
 Aqueous humour formation: 
The three tissue layers of ciliary processes; the capillary wall, the stroma, and 
the two layers of the epithelium are traversed by the aqueous humour constituents. 
They undergo the following process as they pass through these layers. 
 Diffusion : 
It is a biophysical process. Lipid -soluble substances are transported through 
the lipid portions of the membrane proportional to a concentration gradient 
across the membrane (i.e.) Molecules of gas or solution distribute themselves 
uniformly throughout the space they are contained, by the motion of its 
particles.  
 Ultrafiltration 
It is the transport of water and water soluble substances across the cell 
membrane through the protein micropores along the osmotic gradient and 
hydrostatic pressure. 
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 Active Secretion: 
It is responsible for 90% of total aqueous production active transport of charged 
substances against the concentration gradient. This mechanism is believed to be 
mediated by globular proteins in the membrane. Energy is consumed in this 
process. The energy is derived by hydrolysis of adenosine triphosphate (ATP). 
 
  Composition of aqueous humor 
1. 99.9% Water 
2. Protein concentration is 5-16mg/100ml 
3. Glucose – 75% of the plasma concentration. 
4. Electrolytes: 
 Sodium ion is similar in plasma and aqueous. 
 Bicarbonate ion Concentration is increased in the posterior chamber. 
 Chloride  ion  concentration  is  increased  in  aqueous  than plasma and phosphate 
concentration is decreased than plasma. 
      5.Ascorbic acid concentration is very high in aqueous than plasma. 
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INTRAOCULAR PRESSURE 
 
The rate of aqueous production and its outflow determines the Intraocular 
pressure (IOP)  . The average IOP in the general population is around a range of about 
11-21mmHg- two standard deviations either side of average 16 mmHg. 
 
FACTORS INFLUENCING INTRAOCULAR PRESSURE: 
 
1. Heredity: 
 
Relatives of patients with POAG, tend to have increased IOP. 
 
2. Age: 
 
 Increase in IOP with age. 
 
 Related to reduced facility of aqueous outflow and uveoscleral outflow because 
aqueous production also decreases with increasing age. 
3. Gender: 
 
 IOP is equal between the sexes in the age group 20-40 years.  
 In older age- apparent increase in mean IOP with age is higher in women and 
coincides with the onset of menopause. 
 
4. Ethnicity: 
 
 In the United States, blacks have higher IOPs than whites. Recent studies using 
regression analysis of multiple covariates found that black race is not an independent 
risk factor. 
 Full blood Indians in New Mexican tribe – found to have slight lower mean IOP. 
    5.Refractive error: 
 
 Myopes tend to have slight higher IOP. 
 
6. Arterial blood pressure: 
IOP is generally not affected by physiological changes in arterial blood pressure; 
however, sudden large swings may affect the IOP accordingly. 
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7. Systemic venous pressure (SVP): 
Changes in SVP can cause a profound effect on IOP by affecting ipsilateral 
venous pressure, for about 1 mmHg rise in episcleral venous pressure raises the IOP by 
0.8 mmHg. 
          8. Plasma osmolarity:  
It affects the IOP profoundly. When the concentration of solutes in plasma is 
lower than the ocular fluids, the water will enter the eye from plasma and raise the IOP. 
This forms the basis of water drinking test used as a provocative test for glaucoma. 
When the total concentration of the solute molecule in the blood exceeds, the 
water from the eye (vitreous & aqueous) is withdrawn, lowering the IOP. This effect is 
used clinically to lower the IOP by use of hyperosmotic agents like mannitol. 
 
9. Blood pH: 
 
Systemic acidosis lowers the IOP. Metabolic acidosis induced by carbonic 
anhydrase inhibition that is responsible for their pressure lowering effect. 
10. Seasonal variation: 
 
IOP has been recorded as highest during winter and lowest during summer. 
 
11. Diurnal variation in IOP 
 
The IOP is subject to cyclic fluctuations throughout the day. The IOP was 
highest during the early morning and lowest in the late evening. A diurnal variation in 
IOP of more than 8mmHg is considered pathognomic. The physiologic mechanisms 
that regulate diurnal IOP variation are complex. The IOP is regulated in part by 
adrenocortical steroids and catecholamines. 
12. Postural Variation: 
 
Postural variation in IOP showed the consistent elevation of IOP at night time. 
It is physiologically relevant because sleep occurs in the supine position. 
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TONOMETRY 
 
Measurement of Intraocular pressure is termed as Tonometry. 
 
CLASSIFICATION OF TONOMETERS: 
All clinical tonometers measure the IOP by relating a deformation of the globe 
to the force responsible for the deformation. The basic types of tonometers differ 
according to the shape of the deformation. 
 Indentation. 
 
 Applanation (flattening). 
 
 Rebound tonometry 
 
Schiotz tonometer: 
Schiotz built up the principal gadget that evaluated intraocular pressure. It’s 
based on the principles of indentation tonometry. 
Principle 
Indentation tonometry measures amount of deformation of the anterior surface 
of the cornea by a fixed amount of force. The weight of schiotz tonometer on the eye 
elevates the actual IOP (Po) to a higher level (Pt). The change in pressure from actual 
IOP to higher level is an expression of the resistance of scleral rigidity to the 
displacement of fluid. 
Intraocular pressure  with Tonometer  in position  (Pt)  =Actual  IOP  (Po)  +  
Scleral Rigidity (E) 
Determination of actual IOP from a scale reading, Pt requires conversion 
according to Friedenwald conversion tables. Friedenwald generated a formula for the 
linear relationship between the log function of IOP and the ocular distension. 
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Pt = log Po + C V 
 
C a numerical constant, coefficient of ocular rigidity= 0.025 
V is the change in volume 
 
Technique: 
Explain the patient about the procedure and ask him to lie supine, fixing in 
primary position. Topical anaesthetic drops are instilled in the eyes. The foot plate of 
tonometer is kept on the cornea and the reading on the scale is read. It is then 
correlated with the Friedenwald conversion table provided with a tonometer. 
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Goldmann Applanation Tonometer: 
 
Goldmann applanation tonometer consists of a bi-prism mounted on a standard 
slit lamp. An area of 3.06mm of cornea is applanated by the prism. It is the most 
accurate tonometer. 
Principle: 
The principle is based on IMBERT- FICK LAW. The pressure (P) within a 
sphere is roughly equal to the external force (F) needed to flatten a portion of the 
sphere divided by the area (A) of the sphere that is flattened. 
 
P = F/A 
 
Technique: 
Local anaesthetic is administered. Fluorescein dye impregnated paper (0.25%) 
is administered into the lower fornix. The two semicircles are viewed through the slit 
lamp under cobalt blue light at 60⁰.The fluorescein stained tear meniscus facilitates 
visualisation at the margin of the contact between cornea and bi-prism. A central blue 
circle, which is the flattened cornea, surrounded by 2 yellow semi-circles which are the 
tear meniscus is seen. Force against the cornea is adjusted until the inner edges overlap 
by turning measuring dial. 
28 
 
 
 
Potential Errors: 
Overestimated readings 
1. Wide tear meniscus 
2. Unsatisfactory vertical alignment of vertical semicircles 
3. Thick cornea due to increased collagen content of stroma 
4. Increased corneal curvature 
5. Against the rule astigmatism 
 
Underestimated readings 
1. Measurement without use of fluorescein 
2. Inadequate fluorescein concentration 
3. Decreased corneal curvature 
4. With the rule astigmatism 
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GOLDMANN APPLANATION TONOMETER 
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Other tonometer types: 
1. Perkins applanation tonometer 
2. MacKay Marg tonometer 
3. Tono-Pen tonometer 
4. Pneumatic tonometer 
5. Non-contact airpuff tonometer 
6. Optical response analyser 
7. Dynamic contact tonometer (pascal) 
8. Rebound tonometer  
                                          TONO-PEN TONOMETER 
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DYNAMIIC CONTOUR TONOMETRY 
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                               GONIOSCOPY 
 
 
         Gonioscopy, the visualization and assessment of the anterior chamber angle, is an 
essential procedure in the diagnosis and management of glaucoma. The term 
gonioscopy was coined by Trantas in 1907.  
              The anatomy of the eye is such that the angle recess is not visualized by 
routine instrumentation due to total internal reflection of rays emerging from the angle 
recess. The gonioscope was evolved to overcome this optical problem of critical angle.  
 
        
 
34 
 
GONIOSCOPIC ANATOMY AND INTERPRETATION 
 
A methodical evaluation of each structure either from iris plane to Schwalbe’s line  
or from iris plane to Schwalbe’s should curtail errors in interpretation.  
1. The insertion of iris root, may vary from a posterior, anterior or high 
insertions, thereby determining the visibility of the ciliary body band and the 
contour and depth of angle recess.  
2. The ciliary body band is composed of the anterior end of ciliary muscle and is 
seen as a slate gray or dark brown uniform band when insertion of iris root is 
posterior, anterior and high insertions preclude its view. 
3. The scleral spur is the posterior lip of the scleral sulcus and is attached to the 
ciliary body band posteriorly and to the corneoscleral portion of trabecular 
meshwork anteriorly. It is visible as a glistening opaque white line between 
the ciliary body band and trabecular meshwork. 
4. The Trabecular meshwork has a posterior functional, more pigmented portion 
and a less functional nonpigmented anterior portion. The corneoscleral part of 
the meshwork extends from the scleral spur to the Schwalbe’s line.  
5. The Schlemm’s canal is usually not visible, but can be seen through a less 
pigmented posterior trabeculum when reflux blood fills up either due to raised 
episcleral venous pressure, or rarely as a normal phenomenon.  
6. Schwalbe’s line as describes the peripheral termination of the Descemet’s 
membrane.  
 
 
 
 
 
 
35 
 
 
 
 
            GONIOSCOPY BY GOLDMANN 3MIRROR GONIOLENS 
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                                           GLAUCOMA 
Intraocular pressure (IOP) is viewed as the primary hazard factor for the improvement 
and progression of glaucoma. At present, diminishing IOP is the main demonstrated means 
stopping the advancement or potentially progressive OAG 
 
RISK FACTORS FOR DEVELOPING GLAUCOMA  
 
OCULAR RISK FACTORS 
 
QUALITY OF EVIDENCE 
 
1.Intraocular Pressure 
2.Thinner Central Cornea 
3.High Myopia 
4.Disc Haemorrhage 
5.Increased Cup:Disc Ratio 
6.Asymmetric  Cupping 
 
Excellent-Most Important  
Excellent 
Excellent  
Good 
Equivocal 
Equivocal  
 
 
 
NON OCULAR RISK FACTORS 
 
QUALITY OF EVIDENCE 
1. Age 
2. Race 
3. Family history 
4. Adult onset diabetes 
5. Diastolic perfusion pressure 
6. Migraine and peripheral vasospasm 
Excellent 
Excellent 
Excellent 
Equivocal 
Excellent 
Equivocal  
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There is increasing evidence that altered blood flow may play a major role in 
the pathogenesis OAG. The major cause of this reduction in ocular blood flow is 
thought to be secondary to vascular dysregulation in patients, resulting from 
abnormal/insufficient autoregulation. 
CLINICAL STAGING OF GLAUCOMA: 
1. Glaucoma suspects (at risk) 
 Optic disc asymmetry  
 Large physiological cup 
 Low intraocular pressure in early to mid-twenties. 
 Pigment dispersion syndrome  
 Positive family history of visual loss from glaucoma 
 Myopia 
 Hypermetropia 
 Presence of a gene known to be associated with glaucoma 
2. Pre glaucoma 
 IOP above 30mmHg 
 Abnormal disc appearance 
 Narrow occludable anterior chamber angle 
 Abnormal visual field without evidence of definite ocular damage 
3. Glaucoma 
 Asymptomatic glaucoma 
 Definite glaucoma damage but without symptoms 
 Symptomatic glaucoma 
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Pathogenesis of neuronal damage in glaucoma 
       Progressive optic neuropathy results from the death of retinal ganglion cells in a typical 
pattern which results in characteristic optic disc changes and visual field defects. 
 Primary insults 
1. Mechanical theory 
· Elevated IOP led to direct compression and death of the neurons. 
· The entrance of optic nerve is the weakest part of eyeball increase in IOP this 
part pushed out first 
· Increase in intraocular pressure à backward bowing of lamina cribrosa à axonal 
deformation àaxonal transport both orthograde and retrograde flow interrupted 
by compression & also leads to ischemia by altering capillary blood flow à 
neurotropin deprivation à lead to apoptosis of retinal ganglion cells. 
2. Vascular insufficiency theory ( Pressure independent factors): 
                Factors affecting vascular perfusion pressure of optic nerve head are also    
implicated in glaucomatous optic neuropathy which include  
· Defective autoregulatory mechanism of blood flow 
· Systemic hypotension - nocturnal hypotension , patients on anti-hypertensive 
medications 
· Vasospasm 
Secondary insults (excitotoxicity theory): 
· Retinal ganglion cell apoptosis due to glutamate-mediated toxicity. 
· Glutamate is excitatory neurotransmitter à under hypoxic or ischemic 
conditions à glutamate accumulates and reaches toxicity concentration in the 
inter-synaptic junction. 
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GLAUCOMATOUS OPTIC DISC CHANGES: 
A. Definitely pathogenic signs 
 Documented diffuse thinning of neuroretinal rim 
  Acquired pit of optic nerve (pseudo pit) 
 Concentric enlargement of cup 
   B.  Highly suggestive signs 
 Asymmetric cup between eyes >0.2 
 Vertical extension of cup 
 Notching focal loss of neuroretinal rim 
 Localized haemorrhage crossing the disc 
 Bayoneting sign 
 C. Moderate to mildly suggestive signs 
 CD ratio >0.6 
 Localized pallor of optic disc 
 Baring of circumlinear vessels 
 Progressive vascular loops on the optic disc 
 Narrowing of retinal vessels 
 Dilated retinal veins 
 Peripapillary area beta zone atrophy 
  D. Nonspecific signs 
 Nasal shift of disc vessels 
 Alteration of lamina cribrosa 
40 
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VISUAL FIELD LOSS IN GLAUCOMA 
Early defects: 
o Generalized depression 
o Nasal step or depression 
o Temporal wedge or depression 
o Enlargement and baring of blind spot 
o Isolated paracentral scotoma 
 
           Late defects: 
o Arcuate defects 
o Annular scotoma 
o end-stage field, with a small central island and a larger temporal crescent 
remaining. 
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                   NORMOTENSIVE GLAUCOMA 
 
Criteria for normotensive glaucoma: 
1. A mean IOP off treatment consistently equal to less than 21mmHg on diurnal testing,with 
no single reading more than 24mmHg. 
2. Open angle on gonioscopy  
3. Absence of any secondary cause for glaucomatous optic neuropathy 
4. Typical optic disc damage with glaucomatous cupping and loss of neuroretinal rim 
5. Visual field defect compatible with glaucomatous cupping 
6. Progression of glaucomatous damage 
                                    
                                          OCULAR HYPERTENSION 
Ocular hypertension (OHT) is any situation in which intraocular pressure (IOP) is morethan 
than 21 mm Hg 
Ocular hypertension criteria are met: 
 An intraocular pressure greater than 21 mm Hg in either eyes, as measured by 
applanation tonometry on 2 or more occasions  
 Absence of glaucomatous visual field defects on visual-field testing  
 Normal appearance of the optic disc and  retinal nerve fiber layer  
 Anatomically normal, open angles on gonioscopy  
 Absence of ocular conditions contributing to increased IOP, such as narrow angles, 
neovascular conditions, and uveitis.  
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                                               OSAS 
 
Obstructive sleep disorder (OSA) could be a serious disorder that results in several 
systemic and ocular complications. It is characterised with recurrent episodes of upper airway 
obstruction throughout sleep, leading to nocturnal hypoxemia with the symptoms of 
excessive daytime somnolence, riotous snoring, and apnea episodes. 
 The prevalence of OSA is calculable to be about 9% in girls and 24% in men. 
Important clinical consequences of the disorder cover a large spectrum together with daytime 
hypersomnolence, neurocognitive pathology, cardiovascular disease (hypertension, stroke, 
myocardial infarct, heart failure), metabolic pathology, respiratory failure, and cor 
pulmonale.  
Cardiovascular and neurologic morbidity could be a serious outcome of OSA with the 
actual fact that it's seen in about 60% to 70% of patients with stroke or anaemia 
cardiovascular disease. The gold standard procedure in the diagnosis is the overnight 
polysomnography (PSG).  
The main medical treatment choices for the condition are continuous positive airway 
pressure (CPAP) and bilevel positive airway pressure (BiPAP), if CPAP isn't tolerated by the 
patient. Modafinil could be a novel wake-promoting agent, reportable to be an efficient 
adjunct medical aid for residual excessive somnolence in patients treated with CPAP. 
Surgical management choices are restricted to those in whom the medical treatment isn't well 
tolerated or did not achieve success. 
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Apnoeas are defined as entire cessation of oronasal flow lasting greater than 10 
seconds. In the course of those episodes the affected person well-known shows a 
paradoxical motion of the chest wall: that is, in drawing of the chest wall on inspiration, 
as well as reduction in oxygen saturation. Similarly to apnoeas, there can be episodes 
characterized with the aid of a marked reduction (up to 50%) in tidal volume, without 
entire cessation of respiration flow. Such events are termed ‘hypopnoea’. The total wide 
variety of apnoeas and hypopnoea per hour of sleep is called the ‘apnoea / hypopnoea 
index’ (AHI). 
A respiratory effort related arousal event (RERA) is a sequence of breaths 
characterised by increasing effort leading to an arousal from sleep but at the same time 
does not fulfil criteria for apnoea or hypopnoea. Respiratory Distress Index (RDI) is a 
measure which includes apnoea, hypopnoea along with RERAs. Normally individuals  
have AHI of less than five. 
Mild Sleep Apnoea, AHI : 5-15 events per hour 
Moderate Sleep Apnoea, AHI : 15-30 events per hour  
Severe Sleep Apnoea, AHI : greater than 30 events per hour 
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EPWORTH SLEEPINESS SCALE (ESS) 
ESS is the most commonly used questionnaire for subjective assessment of daytime 
sleepiness. All patients were asked how likely they doze off or fall asleep in the following 
situations: 
 Sitting and reading. Watching television. 
 Sitting inactive in a public place. 
 As a car passenger for an hour without break. Lying down to rest in the afternoon. 
 Sitting and talking to someone. 
 Sitting quietly after lunch without alcohol. 
 In a car, while stopping for a few minutes in traffic. 
The following scale was then used to choose the most appropriate number for each situation: 
0= would never doze. 
1= slight chance of dozing. 
2= moderate chance of dozing. 
 3= high chance of dozing. 
Interpretations of ESS: 
(a) Supernormal (if ESS 0–5). 
(b) Normal (if ESS 5–10). 
(c) Sleepy (if ESS 10–15).  
(d) Very sleepy (if ESS 15–20). 
(e) Dangerously sleepy (if ESS > 20). 
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PATHOPHYSIOLOGY OF UPPER AIRWAY OBSTRUCTION IN OSA 
 
The pharynx is a complex structure that serves several important functions 
including speech, swallowing and respiration. The human pharynx is composed of more 
than 20 muscles and is divided into four sections that includes the nasopharynx (from the 
nasal turbinates to the start of the soft palate), velopharynx (from the start of the soft 
palate to the tip of the uvula), oropharynx and hypopharynx.  
The human pharynx can be considered as a collapsible tube that is uniquely 
susceptible to collapse due to the presence of a floating hyoid bone, a longer airway and a 
narrowed  route for inspired oxygen to pass through, when compared to other mammals. 
The presence of soft tissues and bony structures can predispose the pharynx to collapse, 
by increasing the extraluminal tissue pressure, surrounding the upper airway.  
Whereas the pharyngeal dilator muscles maintain pharynx patency due to reflex 
pathways from the CNS and within the pharynx. The presence of these opposing forces 
suggest that increased pharyngeal collapsibility is due to alterations in anatomically 
imposed mechanical loads and/or in dynamic neuromuscular responses to upper airway 
obstruction during sleep. 
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CONTRIBUTION OF ANATOMIC FACTORS TO OSA 
 
OSA is associated with modifications in upper airway anatomy. Structural 
changes including tonsillar hypertrophy, retrognathia, and variations in craniofacial 
structures have been linked to an increased risk of sleep apnea. They cause obstructive 
sleep apnea presumably by increasing upper airway collapsibility. 
 The increased fatty tissue deposition and submucosal edema in the lateral walls of 
the pharynx, both of which narrow the pharyngeal lumen and this may predispose 
to the obstruction during sleep. 
 The genetic susceptibility to OSA is suggested by the structural alterations in the 
lateral pharyngeal walls and tongue, aggregating on a familial basis. 
 The absence of neuromuscular activity demonstrate a reduction in maximal 
pharyngeal area and elevated pharyngeal collapsibility in OSA . 
 Furthermore, obesity, jaw position, acromegaly, tonsillar hypertrophy and a 
smaller bony enclosure surrounding the pharynx have been demonstrated to 
predispose towards pharyngeal collapsibility. 
 Obesity is linked with increased  neck circumference and increased amounts of  
fat around neck. This could narrow and compress the upper airway. Increased 
parapharyngeal fat has been correlated with increased sleep apnea severity. 
 The pressure of fatty tissue around the pharynx increases the risk of upper airway 
collapsibility and possibly offset the effects of dilator muscles that maintain 
airway patency. Obesity may also increase the pharyngeal collapsibility through 
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reduction in the lung volumes, particularly it decreases the functional residual 
capacity, which are accentuated with the onset of sleep.  
CONTRIBUTION OF NEUROMUSCULAR FACTORS TO OSA 
  The anatomically more narrow upper airway in OSA is compensated by the 
increased upper airway dilator muscle activity. Thus, reductions in upper airway 
dilator muscle activity with sleep occurs through serotonergic, cholinergic, 
noradrenergic and histaminergic pathways leads to upper airway obstruction. 
 
 Pressure-sensing mechanisms has a important role in modulating upper airway 
neuromuscular activity during awake and sleep. A negative pressure reflex within 
the upper airway stabilises the upper airway during inspiration. 
 
 The injury to the upper airway due to frequent collapsing and opening of the 
upper airway over time, results in muscle and neuronal fibre injury. 
 
 
 The upper airway sensory pathways are impaired in OSA patients. Their 
temperature sense, two-point discrimination, and vibratory thresholds are 
disrupted in OSA. 
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CONTRIBUTION OF NEUROVENTILATORY FACTORS TO OSA 
Ventilatory control mechanisms play an important role in modulating the 
pharyngeal collapsibility during sleep. Preactivation of the pharyngeal dilator muscles 
stabilizes the upper airway prior to the inflow of air and suggests the central nervous 
system coordination between the upper airway and diaphragm. The central nervous 
stystem  is influenced by the central and peripheral chemoreceptors. 
 With conditions of hypercapnea and hypoxemia it increases the central drive to 
the upper airway and decreases the pharyngeal collapsibility. Increased hypercapnic 
ventilatory responses, prolonged circulatory times, or low oxygen stores within the body 
can result in ventilatory instability that leads to the development of periodic breathing. 
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      POLYSOMNOGRAPHY (PSG) 
 
PSG is the gold standard technique for assessment of sleep disordered breathing. 
Prior to study, patients were advised not to have tea and coffee or any other drugs which 
influences  the quality of sleep such as sedative, hypnotics, tranquilizers, etc. 
Each patient subjected to the sleep laboratory, one hour before his/her usual bed 
time to get familiar and adapt to the environment. The nature and aim of PSG was 
advised to the patient. The duration of PSG was about seven continuous hours. Patients 
were connected cardio-respiratory screening which is a computer-based high technology 
PSG.  
It included: 
             Pulse oximeter applied to the forefinger to detect arterial oxygen saturation 
(SaO2) in terms of; number of desaturation, minimal nocturnal SaO2 (%), baseline 
saturation (%), average saturation (%), number of desaturations <90%, number of 
desaturations <80%, saturation time <90%, and average desaturation (%). 
             A microphone was applied on the neck beside the larynx to detect snoring. 
Thermal sensors and the nasal pressure transducer to detect oronasal air flow. Single lead 
ECG to monitor heart rhythm. Detection of chest and abdominal movements using two 
separate belts. Leg movements were recorded via anterior tibialis electromyogram. 
The following data is  recorded: 
Total sleep time: It is the total duration of light sleep (stages N1 and N2), deep sleep 
(stage N3), and rapid eye movement (REM) sleep. 
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Sleep efficiency: It is the total sleep time divided by the total recording time (i.e., the 
time in bed). 
Sleep stage latency: The latency to any sleep stage is the duration from sleep onset to 
the initiation of that sleep stage. 
Apneoa: defined by, 
a. Reduction in airflow greater than 90% of baseline, recorded by oronasal thermistor 
or nasal pressure cannula. 
b. Duration P10 s. 
c. Reduction in airflow at least 90% of the event. 
An apnea was further classified as obstructive, central or mixed based on the 
assessment of respiratory effort during the event  
Hypopnea: defined by, 
a. Reduction in airflow P50% from baseline, recorded by nasal pressure cannula or 
alternatively by oronasal thermistor. 
b. Duration P10 s. 
c. Reduction in airflow at least 90% of the event. 
d.  Reduction in saturation P4% from baseline prior to the event. 
A desaturation is scored when the following two parameters are met; minimum 
drop required is 4% (the minimum decrease in oxygen level to score a desaturation), 
minimum duration required is 10 s. 
Apnea hypopnea index (AHI): refers to the number of apneas and hypopneas per 
hour of sleep. 
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Respiratory Disturbance Index (RDI): The number of apneas, hypopneas and 
RERAs per hour of sleep 
Snoring index: The number of snoring events per hour of sleep 
                                              POLYSOMNOGRAPHY 
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OCULAR MANIFESTATIONS OF OBSTRUCTIVE SLEEP APNEA 
 
1. FLOPPY EYELID SYNDROME 
 FES is characterized with the clinical findings of flaccid and easily everted upper 
lids, occurring spontaneously or with minimal traction, and chronic papillary 
conjunctivitis of the upper palpebral conjunctiva. Tarsal plaque biopsies of the patients 
with FES revealed the histopathological features as an increase in the elastolytic 
metalloproteinase enzymes and a subsequent decrease in the elastin fibers of the tissue. In 
the literature the prevalence of FES in the OSA population has been reported to vary from 
2% to 32%. Another possible explanation for the underlying mechanism of the 
association between OSA and FES is believed to be the increased venous pressure caused 
by right heart failure and apnea in patients with OSA. 
 
 
2. NON-ARTERITIC ANTERIOR ISCHEMIC OPTIC NEUROPATHY 
An ischemic event may be secondary to impaired optic nerve head blood flow 
autoregulation from apnea. Optic nerve vascular dysregulation may also be a result of 
variations in arterial blood pressure seen in OSA, which may be due to an imbalance 
between nitric oxide and endothelin. Additionally, direct damage by periods of hypoxia 
likely plays a role . Older studies had noted visual field defects consistent with an optic 
neuropathy in patients with OSA, however, data had not demonstrated a direct causal 
relationship between OSA and visual field defects . 
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3. PAPILLEDEMA 
The intracranial pressure of patients with OSA is known to be elevated 
episodically, during the apneic episodes. Cerebral venous dilatation resulting from 
hypercapnia and raised venous pressure due to forced expiration have been suggested as 
the causative factors 
4. CENTRAL SEROUS CHORIORETINOPATHY 
Patients with sleep apnea have increased levels of circulating epinephrine and 
norepinephrine. With elevated levels of catecholamines, OSA has been hypothesized to 
be a direct risk factor for central serous chorioretinopathy (CSCR). 
5. RETINAL VEIN OCCLUSION 
Retinal vein occlusions may be associated with OSA as they may be secondary to 
a slow-down of blood flow circulation secondary to hypoxemia and elevated nocturnal 
intracranial pressure. Strictly acting on the retinal microcirculation, OSA may directly 
have a causal effect on retinal vein occlusions 
6. GLAUCOMA 
 
Several reports in the literature indicated possible associations between OSA and 
primary open angle glaucoma (POAG), normal tension glaucoma (NTG), Ocular 
hypertension (OHT),visual field defects and reduced retinal nerve fiber layer thickness 
(RNFL). The prevalence of glaucoma in OSA being approximately 4 times higher than 
the expected population rate. 
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The pathogenesis of ocular complications in OSA is most likely to have 
multifactorial origin. Vascular and mechanical factors have been contributed for 
developing glaucoma by causing damage to optic nerve.  
Vascular factors are mainly the outcomes of repetitive or prolonged episodes of 
hypoxia; that include direct damage to optic nerve, oxidative stress and inflammation, 
increased vascular resistance, autonomic dysfunction, increased intracranial pressure and 
decreased cerebral perfusion. Repetitive prolonged upper airway obstruction and 
following arousal lead to an increase in the sympathetic tone, thus causing an activation 
in the renin-angiotensin system.  
These factors and the accompanying effect of hypoxia trigger an increase in blood 
pressure and vascular resistance, causing damaging in the vascular endothelium.  All of 
these outcomes lead to the impairment of the autonomic function, an imbalance of 
vasodilatation and vasoconstriction. Furthermore the effect of the arousal periods and 
reperfusion lead to inflammation and oxidative pressure, proven with the aid of the 
expanded degrees of reactive oxygen species and inflammatory markers .  
In the etiologic scope, mechanical factors include supine position and overweight  
associated elevated intraocular pressure(IOP), and intracranial pressure at night, and the 
depletion of fiber in the trabeculum and lamina cribrosa. 
7. KERATOCONUS 
 
Keratoconus is a ecstatic disease of cornea, non inflammatory characterized by 
progressive changes in structural organisation in the corneal collagen, resulting in the 
thinning and steepening of the cornea . It has been linked to floppy eyelid syndrome. 
Since both OSA and keratoconus have been shown to be associated with Floppy eyelid 
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syndrome, a possible direct association between OSA and keratoconus has been recently 
determined. 
 
                                              
                         MANAGEMENT OF OSAS 
OSA must be approached as a chronic disease requiring long-term, 
multidisciplinary management. Treatment of OSA include medical, behavioural and 
surgical options Adjunctive therapies are used as needed to supplement the primary 
treatment options. 
General OSA Outcomes Assessment 
Resolution of sleepiness 
OSA specific quality of life measures 
Patient and spousal satisfaction 
Adherence to therapy 
Avoidance of factors worsening disease 
Obtaining an adequate amount of sleep 
Practicing proper sleep hygiene 
Weight loss for overweight/obese patients 
 
POSITIVE AIRWAY PRESSURE 
Positive airway pressure provides pneumatic splinting of the upper airway and is 
effective in reducing the apnea-hypoapnea index.PAP may be delivered in 
 continuous (CPAP)  
 bilevel (BPAP) 
 autotitrating (APAP) modes 
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PAP given either through a nasal, oral, or oronasal route during sleep is the treatment of 
choice for OSA. CPAP is indicated for the treatment of moderate to severe OSA. 
 
 
 
BEHAVIORAL STRATEGIES 
Behavioral remedy alternatives include weight reduction, ideally to a BMI of 25 
kg/m2 or much less; exercising; positional therapy; and avoidance of alcohol and 
sedatives earlier than bedtime. Successful dietary weight loss can also improve the AHI 
in overweight patients with OSA. Weight reduction must be advocated for all obese OSA 
patients. Weight loss must be adjunct to primary treatment for OSA because of the low 
success rate of dietary programs and the low cure rate by dietary approach alone. 
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           Positional therapy  is an effective secondary therapy, which keeps the patient in a 
non-supine position.  
 
ORAL APPLIANCES 
Custom made oral appliances (OA) may improve upper airway patency during 
sleep by enlarging the upper airway and/or by decreasing upper airway collapsibility 
(e.g., improving upper airway muscle tone). Mandibular repositioning appliances (MRA) 
cover the upper and lower teeth which holds the mandible in an advanced position with 
respect to the resting position. Tongue retaining devices (TRD) hold the tongue in a 
forward position without mandibular repositioning with respect to the resting position.  
        Mandibular repositioning machines (MRA) cover the upper and lower teeth and 
hold the mandible in a propelled position as for the resting position. Tongue holding 
gadgets (TRD) hold just the tongue in a forward position concerning the resting position, 
without mandibular repositioning.  
OAs are demonstrated for use in patients with mild to moderate OSA who lean 
toward OAs to CPAP, or who don't respond to CPAP, are not suitable  for CPAP, or who 
fall flat CPAP or behavioral measures, for example, weight reduction or sleep position 
change. The  OSA must be determined before initiating treatment with OAs to identify 
those patients at risk due to consequences of sleep apnea and to provide a baseline to 
establish the effectiveness of subsequent OA treatment. 
The severity of sleep related respiratory problems must be established in order to 
make an appropriate treatment decision. To ensure maximum satisfactory treatment 
benefit from OAs, patients with OSA should undergo PSG or an attended 
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cardiorespiratory (type 3) sleep study with the oral appliance in place after final 
adjustments of fit have been performed. 
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SURGICAL TREATMENT 
Surgical therapy includes a number of upper airway reconstructive and bypass 
procedures. Primary surgical treatment can be considered in mild OSA who have severe 
obstructing airway that is surgically correctible (e.g., tonsillar hypertrophy obstructing the 
pharyngeal airway). Surgical therapy is considered as a adjunctive  treatment for OSA 
when  PAP therapy is insufficient, such as when the patient is intolerant of PAP, or PAP 
therapy is not able to eliminate OSA.  
Surgery option is considered as a secondary management when there is an 
inadequate treatment outcome with an oral appliance, when the patient is intolerant of the 
OA, or the Oral appliance therapy provides unacceptable improvement of clinical 
outcomes of OSA. Surgery is thought as an additional therapy when obstructive anatomy 
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or functional deficiencies compromise other therapies or to improve tolerance of other 
OSA treatments. 
Common Surgical Procedures for OSA by Site 
Upper Airway Bypass Procedure Tracheotomy 
Nasal Procedures Septoplasty 
 
Functional rhinoplasty 
 
Nasal valve surgery 
 
Turbinate reduction 
 
Nasal polypectomy 
 
Endoscopic procedures 
Oral, Oropharyngeal, and Nasopharyngeal 
Procedures 
Uvulopalatopharyngoplasty and 
variations 
 
Palatal advancement pharyngoplasty 
 
Tonsillectomy and/or adenoidectomy 
 
Excision of tori mandibularis 
 
Palatal implants 
Hypopharyngeal Procedures Tongue Reduction 
 
    Partial glossectomy 
 
    Tongue ablation 
 
    Lingual tonsillectomy 
 
Tongue Advancement/Stabilization 
 
    Genioglossus advancement 
 
    Hyoid suspension 
 
    Mandibular advancement 
 
    Tongue suspension 
Laryngeal Procedures Epiglottoplasty 
 
Hyoid suspension 
Global Airway Procedures Maxillomandibular advancement 
 
Bariatric surgery 
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ADJUNCTIVE THERAPIES 
BARIATRIC SURGERY 
Bariatric surgery is indicated to achieve massive weight loss and in  individuals 
with a  (BMI) ≥ 40 kg/m2 or those with a BMI ≥ 35 kg/m2 with comorbidities and in 
whom dietary measures have been failed. Bariatric surgery must be included as an 
adjunct to less invasive and rapidly active first-line therapies such as PAP for patients 
who have OSA. 
 
PHARMACOLOGIC AGENTS AND OXYGEN THERAPY 
Topical nasal corticosteroids can improve the Apnea Hypoapnea Index in OSAS 
patients  and concurrent rhinitis, and thus may be a useful adjunct to primary therapies for 
OSA . 
Oxygen supplementation is not recommended as a primary treatment for OSA .If 
supplemental oxygen is used as an adjunct to other primary therapies to treat hypoxemia, 
follow-up must include documentation of resolution of the hypoxemia. Supplemental 
oxygen alone may reduce nocturnal hypoxemia but may also prolong apneas and may 
potentially worsen nocturnal hypercapnia in patients with comorbid respiratory disease. 
Modafinil is indicated for the treatment of residual excessive daytime somnolence 
in OSA patients who have apnea inspite of effective PAP treatment. 
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PART-II 
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                                                    AIM 
The Aim of this study was; 
1. To find the prevalence of glaucoma in obstructive sleep apnea patients.  
2. To determine the association between severity of OSAS and glaucoma. 
3. To find the correlation between Apnea-Hypoapnea Index  and IOP, C:D ratio in sleep apnea patients. 
  
MATERIALS AND METHODS 
It is a cross sectional observational study undertaken on a total of 86 patients with 
OSAS who were referred from ENT department of Govt Stanley medical college. Period 
of our study was 1 year from 2016-2017.This study was done in accordance with the 
rules of ethical committee. All patients were informed about the purpose of the study and 
an informed consent was obtained. An overnight polysomnography was performed in all 
patients in sleep lab of ENT department and they were categorized based on AHI. 
 OSAS was classified as AHI(apnea/hypopnea index) more than 5. 
1.  Mild (AHI, 5-15),  
2. Moderate (AHI, 15-30) 
3.  Severe (AHI >30). 
•  Simultaneous measurement of BMI (body mass index) and a complete 
ophthalmologic examination which included best corrected visual acuity, 
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Goldman tonometry, visualfields, gonioscopy ,ultrasound pachymetry and fundus 
examination were performed for each subject.  
•  For patients with a suspected optic nerve cup or glaucoma, visual field was 
measured by octopus automated perimetry. 
•  For examination of optic disc morphology, Stereoscopic slit-lamp biomicroscopy 
with a 90D lens was used.  
• Patients who had normal IOP and fundus findings suggestive of normotensive 
glaucoma were subjected to measurement of central corneal thickness with 
ultrasound pachymetry. 
 
• AHI, IOP, glaucomatous optic disc changes, and diagnosis of glaucoma were 
measured as main outcome measures in this study 
 
INCLUSION CRITERIA 
• Adults 18-80yrs 
• patients with increased BMI >25 
• H/O snoring 
• excessive daytime sleepiness 
• AHI>5 
EXCLUSION CRITERIA 
•  Any form of ocular surgery  
68 
 
• severe cataract 
• congenital optic disc anomalies 
• known glaucoma patients on treatment 
• secondary glaucomas and angle closure glaucoma  
• pre existing visual field defect due to other ocular conditions. 
 
The data was analysed using SPSS PACKAGE (statistical analysis 
 
of social science) version 16 and Microsoft excel 2007. 
 
 
The following statistical analyses were used in this study 
 
 
a. Percentage analysis was calculated to find the exact percentage of patients 
 
b. The mean score was calculated to find the average responses from the patients. 
 
c. Standard deviations were also calculated to find the level of deviations among the 
patients. 
 
d. Paired sample 't' test, one way ANOVA was used to find the significance difference 
between variables. 
 
This helped in interpretation and interpreted data was summarized in 
percentage. Diagrams and tables were also used to highlight the interpretation. 
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                                                                OBSERVATIONS 
Age  
 
 
 
Age Groups 
With 
Glaucoma 
Group 
% 
Without 
Glaucoma 
Group 
% Overall % 
≤ 30 years 0 0.00 3 4.76 3 3.49 
31-50 years 0 0.00 21 33.33 21 24.42 
51-70 years 19 82.61 35 55.56 54 62.79 
> 70 years 4 17.39 4 6.35 8 9.30 
Total 23 100.00 63 100.00 86 100.00 
 
 
 
Maximum OSAS patients either with or without glaucoma belonged to age group 51-70 yrs. But the 
mean age for glaucoma group was 64.78 and without glaucoma group was 52.86. This implies that there 
is a strong relationship between increase in age and the development of glaucoma. 
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Age Distribution 
With Glaucoma 
Group 
Without Glaucoma 
Group 
Overall 
Mean 64.78 52.86 56.05 
SD 7.19 12.76 12.66 
P value  
Unpaired t Test 
0.0001 
 
Gender  
 
 
 
Gender 
Status 
With 
Glaucoma 
Group 
% 
Without 
Glaucoma 
Group 
% Overall % 
Male 14 60.87 42 66.67 56 65.12 
Female 9 39.13 21 33.33 30 34.88 
Total 23 100.00 63 100.00 86 100.00 
P value  
Chi Squared Test 
0.6181 
 
About 61% were males and 39% were females among OSAS patients who developed glaucoma. 
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BMI 
 
 
 
BMI Groups 
With 
Glaucoma 
Group 
% 
Without 
Glaucoma 
Group 
% Overall % 
<25 4 17.39 4 6.35 8 9.30 
25-30 9 39.13 48 76.19 57 66.28 
          >30 10 43.48 11 17.46 21 24.42 
0 0 0.00 0 0.00 0 0.00 
Total 23 100.00 63 100.00 86 100.00 
 
Among patients who were diagnosed as glaucoma, 4 patients had BMI <25, 9 patients had 
BMI between 25-30, 10 patients had severe obesity with BMI >30. Mean BMI in glaucoma 
group was found to be 28.43. 
 
BMI Distribution 
With Glaucoma 
Group 
Without Glaucoma 
Group 
Overall 
Mean 28.43 27.22 27.55 
SD 3.31 2.74 2.94 
P value  
Unpaired t Test 
0.0403 
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Obstructive Sleep Apnea - AHI 
 
 
 
Obstructive 
Sleep Apnea 
Groups 
With 
Glaucoma 
Group 
% 
Without 
Glaucoma 
Group 
% Total % 
Mild 
(5<AHI<15) 
3 13.04 20 31.75 23 26.74 
Moderate 
(15<AHI<30) 
7 30.43 28 44.44 35 40.70 
Severe 
(>30AHI) 
13 56.52 15 23.81 28 32.56 
Total 23 100.00 63 100.00 86 100.00 
 
Nearly 56% (13 glaucoma patients) who were diagnosed with glaucoma had AHI >30.Only 3 patients 
with mild OSAS had glaucoma. 
 
 
 
AHI (Obstructive Sleep 
Apnea) Distribution 
With Glaucoma 
Group 
Without Glaucoma 
Group 
Overall 
Mean 30.48 21.98 24.26 
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SD 11.14 11.46 11.93 
P value  
Unpaired t Test 
0.0029 
 
 
Intraocular Pressure  
 
 
 
Intraocular 
Pressure  
With 
Glaucoma 
Group 
% 
Without 
Glaucoma 
Group 
% Overall % 
Normal 14 60.86 63 100.00 77 89.53 
Elevated 9 39.13 0 0.00 9 10.46 
Total 23 100.00 63 100.00 86 100.00 
 
About 61%(14 pts) of patients with OSAS developed normotensive glaucoma.39% had POAG. 
 
Intraocular Pressure OD 
Distribution 
With Glaucoma 
Group 
Without Glaucoma 
Group 
Overall 
Mean 23.13 14.35 16.70 
SD 4.04 1.92 4.71 
P value  
Unpaired t Test 
<0.0001 
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Cup–Disc Ratio OD 
 
 
 
Cup–Disc 
Ratio OD 
Groups 
With 
Glaucoma 
Group 
% 
Without 
Glaucoma 
Group 
% Overall % 
≤ 0.3 0 8.70 54 85.71 54 65.12 
0.4-0.7 14 52.17 9 14.29 23 24.42 
> 0.7 9 39.13 0 0.00 9 10.47 
Total 23 100.00 63 100.00 86 100.00 
 
 
Cup–Disc Ratio OD 
Distribution 
With Glaucoma 
Group 
Without Glaucoma 
Group 
Overall 
Mean 0.67 0.32 0.41 
SD 0.18 0.05 0.19 
P value  
Unpaired t Test 
<0.0001 
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Cup–Disc Ratio OS 
 
 
 
Cup–Disc 
Ratio OS 
Groups 
With 
Glaucoma 
Group 
% 
Without 
Glaucoma 
Group 
% Overall % 
≤ 0.3 0 8.70 50 79.37 52 60.47 
0.4-0.7 14 52.17 13 20.63 25 29.07 
> 0.7 9 39.13 0 0.00 9 10.47 
Total 23 100.00 63 100.00 86 100.00 
 
Nearly 39% had glaucoma with severe cupping and 52% had moderate  glaucomatous cupping. mean 
cup disc ratio was found to be 0.6. 
 
Cup–Disc Ratio OS 
Distribution 
With Glaucoma 
Group 
Without Glaucoma 
Group 
Overall 
Mean 0.67 0.32 0.42 
SD 0.20 0.05 0.19 
P value  
Unpaired t Test 
<0.0001 
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Visual Fields OD 
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Visual Fields OD 
With 
Glaucoma 
Group 
% 
Without 
Glaucoma 
Group 
% Overall % 
Normal 0 8.70 63 100.00 63 75.58 
DAS 2 8.70 0 0.00 2 2.33 
IAS,ISAS 6 26.09 0 0.00 6 6.98 
IIAS 2 8.70 0 0.00 2 2.33 
PCS 2 8.70 0 0.00 2 2.33 
SAS 6 26.09 0 0.00 6 6.98 
Reduced Sensitivity in 
IAA 
3 13.04 0 0.00 3 3.49 
Total 23 100.00 63 100.00 86 100.00 
P value  
Chi Squared Test 
<0.0001 
 
Most of the patients had IAS,ISAS AND SAS contributing to 26%.  
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Visual Fields OS 
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Visual Fields OS 
With 
Glaucoma 
Group 
% 
Without 
Glaucoma 
Group 
% Overall % 
Normal 5 21.74 63 100.00 68 79.07 
DAS 3 13.04 0 0.00 3 3.49 
IAS,ISAS 5 21.74 0 0.00 5 5.81 
IIAS 1 4.35 0 0.00 1 1.16 
PCS 1 4.35 0 0.00 1 1.16 
SAS 6 26.09 0 0.00 6 6.98 
Depression in SA Area 2 8.70 0 0.00 2 2.33 
Total 23 100.00 63 100.00 86 100.00 
P value  
Chi Squared Test 
<0.0001 
 
 5 patients had field defects in right eye where as left eye was normal..About 26% of OSAS 
patients had SAS implying moderate to severe glaucomatous cupping. 
PREVALENCE OF GLAUCOMA IN OSAS PATIENTS 
 
80 
 
 
AHI Vs IOP  
 
 
 
Correlation Statistics – AHI Vs IOP  
Pearson’s R 0.32 
R Square 0.08 
P value 
ANOVA 
0.0035 
 
Correlation between AHI and Intraocular pressure was statistically significant(P value-0.0035) 
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Patients' clinical characteristics, polysomnography parameters and ocular examination 
CHARACTERISTICS WITH GLAUCOMA  
WITHOUT 
GLAUCOMA 
P VALUE 
Age  64.78±7.19 52.86±12.76 0.0001 
BMI 28.43±3.31 27.22± 2.74 0.09 
AHI 30.48± 11.14 21.98 ±11.46 0.0029 
IOP OD 23.13± 4.04 OD 14.35± 1.92 <0.0001 
 OS 23.04 ±4.17 OS 14.13± 1.72 <0.0001 
C:D ratio OD 0.67 ±0.18 OD 0.32± 0.05 <0.0001 
 OS 0.67± 0.20 OS 0.32 ±0.05 <0.0001 
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AHI Vs C:D  
 
 
 
 
Correlation Statistics – AHI Vs C:D  
Pearson’s R 0.32 
R Square 0.10 
P value 
ANOVA 
0.0028 
 
There was a significant positive statistical correlation between AHI and C:D ratio.  
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                                   RESULTS 
A total of 86 patients were included in the study.All the recruited patients were within 
inclusion criteria of our study. 
The following were the results of our study: 
1. Out of 86 patients,56 (65%) were men and 30 (35%) were women who belonged to 
age group 18-80 yrs 
2. There were 8 (9.3%) patients who had BMI <25, 57 (66.4%) patients with BMI in the 
range 25-30 and 21 patients with BMI >25 (25.3%). 
3. Nearly 23 (26.7%) patients had mild OSAS,  35 (40.7%)had moderate OSAS, 28 
(32.5%)patients had severe OSAS. 
4. The prevalence of glaucoma in these OSAS group of patients were found to be 
26.7%.Out of this 86 OSAS patients nearly 23 patients developed glaucoma.Among 
the glaucoma patients, about 14 (60.8%) who had reduced central corneal thickness by 
ultrasound pachymetry  were diagnosed as normotensive glaucoma, 9 (39.1%) patients 
diagnosed with POAG. 
5. Among 14 NTG patients,2 patients presented with splinter haemorrhages in optic disc. 
6. Of the 23 patients diagnosed with glaucoma,13 patients had severe OSAS implying 
that increasing severity of OSAS contributes to development of glaucoma,which was 
statistically significant. 
7. There was significant correlation between the presence of glaucoma and age,  apnea 
hypopnea index (AHI), and body mass index (BMI).So as the BMI increases IOP also 
increases. 
8. A significant positive correlation with AHI was documented for IOP and cup/disc 
ratio. 
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                                                DISCUSSION 
Our study reveals the prevalence of glaucoma to be increased in OSAS patients. In 
1982, Walsh and Montplaisir first described an association between OSAS and glaucoma in 
five patients in two generations within the same family. A relatively increased prevalence of 
glaucoma was later observed in patients with OSAS. However pathophysiological 
mechanisms behind the development of glaucoma in osas patients is multifactorial 
.Obstructive sleep apnea (OSA) is one of the systemic risk factors for glaucoma which 
causes irreversible visual field (VF) damage. The relationship between OSAS and glaucoma 
may be dependent upon IOP or IOP-independent risk factors. Raised IOP is noted which is 
possibly related to obesity, supine position during sleep, and raised intracranial pressure. 
               Pathophysiology of Glaucoma in Obstructive Sleep Apnea 
 Repetitive AH episodes or reduced ventilatory drive will cause hypoxia 
and hypercapnia which will decreases po2 and  increases  pco2. These 
prolonged episodes of hypoxia directly damage the ONH, retinal 
ganglion cells (RGC’s), and its axons. Hypoxia will cause oxidative 
stress and inflammation by increasing of reactive oxygen species and 
inflammatory markers which subsequently leads to mitochondrial 
dysfunction of RGC’s and glaucoma. 
 Retina and optic nerve require constant blood flow to meet their high 
metabolic needs. OSA causes insufficient blood supply and nourishment 
to the RNFL and optic nerve. 
 Internal Carotid artery  supplies blood to the brain through either side of 
neck. OSA will cause vascular cell wall changes in carotid artery by 
85 
 
building the plaque    formation inside the wall. It narrows the blood 
vessels and ends up in optic nerve head ischemia. 
 Hypoxia causes oxidative stress, inflammation and decreases availability 
of nitric oxide which is vasodilator and damages the endothelium. It will 
increase the level of endothelin‑1 which is a powerful vasoconstrictor. 
Production of endothelin‑1 is also found to be higher in OSA ,which 
leads to severe impairment of vasodilator response of blood vessels. 
Hypoxia‑induced endothelin‑1 and nitric oxide imbalance in OSA 
causes vascular dysregulation and affects blood flow of ONH and retina. 
 As a result of vascular dysregulation, ischemia and abnormal perfusion 
pressure optic nerve may be more sensitive even for normal IOP to get 
damaged .Apart from supine position at night during sleep, obesity is also 
one of the risk factors for high IOP due to excessive intraorbital adipose 
tissue and increased episcleral venous pressure. 
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MECHANISM’S INVOLVED PATHOPHYSIOLOGY OF GLAUCOMA IN OBSTRUCTIVE 
SLEEP APNEA 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Walsh and Montplaisir initially described the association of OSA and glaucoma in 1982. They 
diagnosed glaucoma in five patients of two generations in the same family with OSA. Mojon et al. 
reported that the prevalence of glaucoma in 69 patients with OSA was 7.2%.  Karakucuk et al., Sergi 
and one study in Thailand reported an increase prevalence of glaucoma (12.9%, 5.9% and 13.6%; 
respectively) in patients diagnosed OSA . The highest prevalence of glaucoma (27%) in these patients 
was  reported by Bendel et al. among 100 patients. 
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Studies reported the prevalence of glaucoma in obstructive sleep apnea patients  
 
 
 
 
                                                                       
 
 
 
Study Sample Study design Type of Results Significance of 
 Characteristics  glaucoma  Association 
Lin et al., 2013[22] 1012 ‑ OSA Retrospective, cohort Both Incidence rate in OSA Yes 
 6072 ‑ Normals Study  11.6, in normals 6.76  
Chen et al., 2014[23] 2528 ‑ OSA Retrospective, Both Hazard ratio of glaucoma Yes 
 10,112 ‑ Normals population‑based  1.88  
  Study    
Bendel et al., 100 OSA Cross‑sectional, case POAG Prevalence 27% Yes 
2008[24] Patients Series    
Muniesa et al., 75 OSA without Cross‑sectional POAG Prevalence 5.33% in Significantly associated 
2014[27] FES52 OSA   without FES, 23.07% in with floppy eyelid 
 with FES25   with FES in OSA syndrome in OSA 
 Normals     
Lin et al., 2011[26] 209 ‑ OSA Cross‑sectional NTG Prevalence of NTG Yes, higher prevalence in 
 38 ‑ normals   12/209, 5.7% moderate/severe OSA 
Geyer et al., 2003[28] 228 ‑ OSA Cross‑sectional POAG Prevalence of POAG Prevalence of glaucoma 
    5/228, 2% in OSA similar to 
     Caucasians 
Mojon et al., 1999[21] 69 ‑ OSA Cross‑sectional POAG Prevalence 7.2% Yes, higher than 
 45 ‑ normals    expected normal 
     Population 
Hashim et al., 39 ‑ OSA Longitudinal Both Prevalence 8/39 (20.5%) Yes 
2014[25]    6 NTG, 2 POAG  
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                                                                     CONCLUSION 
In our study, the prevalence of glaucoma in people with sleep apnea was 27%. This 
indicates the high prevalence of glaucoma in these patients compared to the general 
population (2%) similar to previous studies and suggests a high correlation between 
glaucoma and sleep apnea. It can be  recognized as a new risk factor in the incidence of 
glaucoma . 
 
The results of this research were different from some previous studies. The first study 
was published by Geyer et al. and suggested a prevalence of glaucoma only 0.2% among 
228 patients with glaucoma that these were not significantly different from that of the 
general Caucasian population . 
              According to these findings, the prevalence of POAG in OSA patients was 
higher than the general population in the same age group. Thus it is mandatory to screen 
OSAS patients for glaucomatous changes earlier to prevent the progression and 
complication of glaucoma. 
 
 
 
 
 
 
 
89 
 
                     
 
 
 
 
                                               ANNEXURES  
                                                               
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
90 
 
                                                             BIBLIOGRAPHY 
1. Becker-shaffer’s Diagnosis and Therapy of the glaucomas by Rombert L Stamper,M 
 
2. Bruce Shields – The glaucomas – Clinical sciences – volume 2. 
 
3. Kanski clinical ophthalmology. 
 
4. Tarek. M .Eid –George . L . Spaeth – The Glaucomas – Concepts and Fundamentals. 
 
5. Royal College of Ophthalmologists; Glaucoma Annual Evidence Update; 2008.  
 
6. Stradling  JR,  Davies  RJ.  Sleep  1:  Obstructive  sleep  apnoea/hypopnoea syndrome: 
Definitions, epidemiology, and natural history.Thorax 2004;59:73‑8. 
 
7. Rivas M, Ratra A, Nugent K. Obstructive sleep apnea and its effects on cardiovascular 
diseases: A narrative review. Anatol J Cardiol 2015;15:944‑50. 
 
8. McNab AA. The eye and sleep. Clin Exp Ophthalmol 2005;33:117‑25. 
 
9. Stansbury RC, Strollo PJ. Clinical manifestations of sleep apnea. J Thorac Dis 
2015;7:E298‑310. 
 
10. Boonyaleephan S, Neruntarat C. The association of primary open-angle glaucoma/normal 
tension glaucoma and obstructive sleep apnea in Thai patients. J Med Health Sci 2008 
 
11. Bilgin G. Normal‑tension glaucoma and obstructive sleep apnea syndrome: A prospective 
study. BMC Ophthalmol 2014 
 
12. Walsh JT, Montplaisir J. Familial glaucoma with sleep apnoea: A new syndrome Thorax 
1982;37: 
 
13. Mojon DS, Hess CW, Goldblum D, Fleischhauer J, Koerner F, Bassetti C, et al. High 
prevalence of glaucoma in patients with sleep apnea syndrome. Ophthalmology 
1999;106:1009‑12. 
 
14. Bendel RE, Kaplan J, Heckman M, Fredrickson PA, Lin SC. Prevalence of glaucoma in 
patients with obstructive sleep apnoea – cross‑sectional case‑series. Eye (Lond) 
91 
 
2008;22:1105‑9. Hashim SP, Al Mansouri FA, Farouk M, Al Hashemi AA, Singh R. 
Prevalence of glaucoma in patients with moderate to severe obstructive sleep apnea: Ocular 
morbidity and outcomes in a 3 year follow‑up study. Eye (Lond) 2014;28:1304‑9. 
 
15. Lin PW, Friedman M, Lin HC, Chang HW, Wilson M, Lin MC. Normal tension glaucoma in 
patients with obstructive sleep apnea/hypopnea syndrome. J Glaucoma 2011;20:553‑8. 
 
16. Oman Journal of Ophthalmology, Vol. 9, No. 3, 2016 
 
17. Kadyan A, Asghar J, Dowson L, Sandramouli S. Ocular findings in sleep apnoea patients 
using continuous positive airway pressure. Eye (Lond) 2010;24:843‑50. 
 
18. Sergi M, Salerno DE, Rizzi M, Blini M, Andreoli A, Messenio D, et al. Prevalence of normal 
tension glaucoma in obstructive sleep apnea syndrome patients. J Glaucoma 2007;16:42‑6. 
 
19. Karakucuk S, Goktas S, Aksu M, Erdogan N, Demirci S, Oner A, et al. Ocular blood flow in 
patients with obstructive sleep apnea syndrome (OSAS). 
 
20. Graefes Arch Clin Exp Ophthalmol 2008;246:129‑34. 
 
21. Mojon DS, Hess CW, Goldblum D, Boehnke M, Koerner F, Gugger M, et al. Normal‑tension 
glaucoma is associated with sleep apnea syndrome. Ophthalmologica 2002;216:180‑4. 
 
22. Blumen Ohana E, Blumen MB, Bluwol E, Derri M, Chabolle F, Nordmann JP. Primary open 
angle glaucoma and snoring: Prevalence of OSAS. Eur Ann Otorhinolaryngol Head Neck Dis 
2010;127:159‑64. 
 
23. Balbay EG, Balbay O, Annakkaya AN, Suner KO, Yuksel H, Tunç M, et al. Obstructive sleep 
apnoea syndrome in patients with primary open‑angle glaucoma. Hong Kong Med J 
2014;20:379‑85. 
 
24. Remmers JE, deGroot WJ, Sauerland EK, et al. Pathogenesis of upper airway occlusion during 
sleep. J Appl Physiol 1978;44:931–938. [PubMed: 670014] 
 
25. Ryan CM, Bradley TD. Pathogenesis of obstructive sleep apnea. J Appl Physiol 
2005;99:2440–2450. [PubMed: 16288102] 
 
92 
 
26. Strollo PJ Jr, Rogers R. Current concepts: obstructive sleep apnea. N Engl J Med 1996; 334: 
99–104. 
 
27. Waller EW, Bendel RE, Kaplan J. Sleep disorders and the eye. Mayo Clin Proc 2008; 83: 
1251–61. 
 
28. Mojon DS, Hess CW, Goldblum D et al. High preva-lence of glaucoma in patients with sleep 
apnea syndrome. Ophthalmology 1999; 106: 1009–12.  
 
29. Lin PW, Friedman MW, Lin HC, Chang HW, Wilson M, Lin MC. Normal tension glaucoma 
in patients with obstructive sleep apnea/hypopnea syndrome. J Glaucoma 2011; 20: 553–8. 
 
30. Mojon DS, Hess CW, Goldblum D, Böhnke M, Körner F, Mathis J. Primary open-angle 
glaucoma is associ-ated with sleep apnea syndrome. Ophthalmologica 2000; 214: 115–18. 
 
31. Mojon DS, Hess CW, Goldblum D et al. Normal-tension glaucoma is associated with sleep 
apnea syndrome. Ophthalmologica 2002; 216: 180–4. 
 
32. Marcus DM, Costarides AP, Gokhale P et al. Sleep disorders: a risk factor for normal-tension 
glaucoma? J Glaucoma 2001; 10: 177–83. 
 
33. Blumen Ohana E, Blumen MB, Bluwol E, Derri M, Chabolle F, Nordmann JP. Primary open 
angle glaucoma and snoring: prevalence of OSAS. Eur Ann Otorhinolaryngol Head Neck Dis 
2010; 127: 159–64. 
 
34. Girkin CA, McGwin G Jr, McNeal SF, Owsley C. Is there an association between pre-existing 
sleep apnoea and the development of glaucoma? Br J Oph-thalmol 2006; 90: 679–81. 
 
35. Klein BEK, Klein R, Sponsel WE et al. Prevalence of Glaucoma: the beaver dam eye study. 
Ophthalmology 1992; 99: 1499–504. 
 
36. Tsang CSL, Chong SL, Ho CK, Li MF. Moderate to severe obstructive sleep apnoea patients is 
associated with a higher incidence of visual field defects. Eye 2006; 20: 38–42. 
 
37. Kargi SH, Altin R, Koksal M et al. Retinal nerve fibre layer measurements are reduced in 
patients with obstructive sleep apnea syndrome. Eye 2005; 19: 575–9. 
 
38. Lin PW, Friedman M, Lin HC, Chang HW, Pulver TM, Chin CH. Decreased retinal nerve 
fiber layer thickness in patients with obstructive sleep apnea/ hypopnea syndrome. Graefes 
Arch Clin Exp Ophthalmol 2011; 249: 585–93. 
 
 
93 
 
 
                                                        PROFORMA  
  
• Serial no.               : 
•  Name                  : 
• Age          :  
•  Sex          :  
•  Occupation      :  
•  Address         :  
•  Ocular complaints    :  
•  Ass. Systemic illness   :  
•  Family  history         :  
•  Symptoms             :  
•  WEIGHT AND HEIGHT :  
•  BODY MASS INDEX   :  
•  POLYSOMNOGRAPHY-AHI:  
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• BASELINE  OCULAR  EXAMINATION                                                                               
                                                                                                  RE                    LE  
• Vision  
•  Eyelids and lashes  
•  Extraocular movements   
• Slit lamp examination  
•  Conjunctiva  
•  Cornea  
•  Anterior chamber  
• Iris  
• Pupil  
•  Lens  
•  REFRACTION  
•  IOP(GOLDMAN TONOMETRY)    
• GONIOSCOPY  
• VISUAL FIEDS  
• FUNDUS EXAMINATION  
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                                KEY TO MASTERCHART 
BCVA-BEST CORRECTED VISUAL ACUITY 
IOP-INTRAOCULAR PRESSURE 
OD-RIGHT EYE 
OS-LEFT EYE 
AHI-APNEA-HYPOAPNEA INDEX 
BMI-BODY MASS INDEX 
SAS-SUPERIOR ARCUATE SCOTOMA 
IAS-INFERIOR ARCUATE SCOTOMA 
DAS-DOUBLE ARCUATE SCOTOMA 
IIAS-INCOMPLETE INFERIOR ARCUATE SCOTOMA 
PCS-PARACENTRAL SCOTOMA 
NTG-NORMOTENSIVE GLAUCOMA 
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